EUVIMEDEUVIMED entdecken
Crossref

Knockdown of deoxythymidylate kinase suppresses progression and epithelial-mesenchymal-transition of lung adenocarcinoma via STAT3 signaling

Fengqiang Yu iD, Yanxun Chen, Ruiqin Qiu, Nanlong Lin, Yinhe Yin, Yi Zhuo, Jianbo Lin, Fancai Lai

Physiological Genomics · 2023

DOI: 10.1152/physiolgenomics.00001.2023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Physiological Genomics, 2023. Verfasst von Fengqiang Yu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, the First Affiliated Hospital, Fujian Medical University, Fuzhou, China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Fujian Provincial Health Commission, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

DTYMK plays an important role in progression of LUAD through the STAT3 signaling pathway. YMU1 may serve as a novel drug to suppress the development of LUAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungLung NeoplasmsHumansThymidine MonophosphateSignal TransductionLungCell ProliferationCell MovementGene Expression Regulation, NeoplasticSTAT3 Transcription Factor

Stichwörter der Autor:innen

DTYMKEMTSTAT3YMU1lung adenocarcinoma

Substanzen

Thymidine MonophosphateSTAT3 protein, humanSTAT3 Transcription Factor

Autor:innen und Institutionen

  • Department of Thoracic Surgery, the First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
  • Department of Thoracic Surgery, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
  • Department of Thoracic Surgery, Quangang District Hospital, Quanzhou, China.

ORCID-Profile: Fengqiang Yu

Förderung

  • Fujian Provincial Health Commission
  • National Natural Science Foundation of China

Zitieren

APA

Yu, F., Chen, Y., Qiu, R., Lin, N., Yin, Y., Zhuo, Y., Lin, J., & Lai, F. (2023). Knockdown of deoxythymidylate kinase suppresses progression and epithelial-mesenchymal-transition of lung adenocarcinoma via STAT3 signaling. Physiological Genomics. https://doi.org/10.1152/physiolgenomics.00001.2023

Vancouver

Yu F, Chen Y, Qiu R, Lin N, Yin Y, Zhuo Y, et al. Knockdown of deoxythymidylate kinase suppresses progression and epithelial-mesenchymal-transition of lung adenocarcinoma via STAT3 signaling. Physiological Genomics. 2023. doi:10.1152/physiolgenomics.00001.2023

BibTeX
@article{Yu2023,
  author = {Yu, Fengqiang and Chen, Yanxun and Qiu, Ruiqin and Lin, Nanlong and Yin, Yinhe and Zhuo, Yi and Lin, Jianbo and Lai, Fancai},
  title = {Knockdown of deoxythymidylate kinase suppresses progression and epithelial-mesenchymal-transition of lung adenocarcinoma via STAT3 signaling},
  journal = {Physiological Genomics},
  year = {2023},
  doi = {10.1152/physiolgenomics.00001.2023}
}
Kostenlos starten →